| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/24/2020 |
GN
| Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib |
| 10/08/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 09/30/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/30/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 09/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 09/28/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 09/28/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 09/28/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/28/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/22/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/22/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/17/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/17/2020 |
GN
| Principia Announces First Patient Dosed in Phase 2A Trial of Rilzabrutinib in IgG4-Related Disease |
| 09/14/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 09/14/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 09/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/02/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of PRNB, CBMG, PFNX, and VAR Buyouts |
| 09/01/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cancer Genetics, Inc., Momenta Pharmaceuticals, Inc., Principia Biopharma Inc., and Yintech Investment Holdings Limited |
| 08/28/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 08/28/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 08/25/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/20/2020 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/19/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/17/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/17/2020 |
GN
| PRINCIPIA BIOPHARMA INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
| 08/17/2020 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 08/17/2020 |
8-K
| Quarterly results |
| 08/06/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 08/06/2020 |
8-K
| Quarterly results |
| 06/26/2020 |
8-K
| Quarterly results |
|